MARKET

SPHRY

SPHRY

Starpharma Holdings Ltd
OTCQX
2.300
-0.040
-1.71%
Closed 11:59 01/16 EST
OPEN
2.300
PREV CLOSE
2.340
HIGH
2.300
LOW
2.300
VOLUME
1.10K
TURNOVER
2.53K
52 WEEK HIGH
2.750
52 WEEK LOW
0.489
MARKET CAP
--
P/E (TTM)
-14.6125
1D
5D
1M
3M
1Y
5Y
1D
Radiopharm Theranostics Partners with Starpharma to Develop Novel Radiopharmaceutical Using DEP® Platform
Reuters · 09/30/2025 10:05
Starpharma Holdings Limited Announces Collaboration and License Agreement with Genentech for Cancer Therapy Development
Reuters · 09/22/2025 11:30
STARPHARMA ANNOUNCES A COLLABORATION AND LICENSE AGREEMENT WITH GENENTECH
Reuters · 09/22/2025 11:30
Weekly Report: what happened at SPHRY last week (0908-0912)?
Weekly Report · 09/15/2025 11:00
Weekly Report: what happened at SPHRY last week (0901-0905)?
Weekly Report · 09/08/2025 11:02
Weekly Report: what happened at SPHRY last week (0825-0829)?
Weekly Report · 09/01/2025 10:58
STARPHARMA FY NET INCOME AUD -10 MILLION
Reuters · 08/26/2025 00:48
Weekly Report: what happened at SPHRY last week (0818-0822)?
Weekly Report · 08/25/2025 11:08
More
About SPHRY
Starpharma Holdings Limited is an Australia-based biotechnology company specializing in advancing dendrimer technology. The Company's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The Company's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. It also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The Company has applied its DEP technology to the innovative area of antibody-drug conjugates.

Webull offers Starpharma Holdings Ltd stock information, including OTCQX: SPHRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHRY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPHRY stock methods without spending real money on the virtual paper trading platform.